Patents Assigned to Crystal Bioscience Inc.
-
Patent number: 10362770Abstract: A transgenic animal is provided. In certain embodiments, the transgenic animal comprises a genome comprising: an immunoglobulin light chain locus comprising: a) a functional immunoglobulin light chain gene comprising a transcribed variable region encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of 2 to 5 different amino acids; and ii. a light chain framework; and, operably linked to the functional immunoglobulin light chain gene: b) a plurality of pseudogene light chain variable regions each encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of the same 2 to 5 different amino acids as the CDRs of the functional gene; and ii. a light chain framework that is identical in amino acid sequence to the light chain framework of the transcribed variable region.Type: GrantFiled: December 4, 2018Date of Patent: July 30, 2019Assignee: Crystal Bioscience Inc.Inventors: William Don Harriman, Robert Etches, Philip A. Leighton
-
Patent number: 10172334Abstract: A transgenic animal is provided. In certain embodiments, the transgenic animal comprises a genome comprising: an immunoglobulin light chain locus comprising: a) a functional immunoglobulin light chain gene comprising a transcribed variable region encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of 2 to 5 different amino acids; and ii. a light chain framework; and, operably linked to the functional immunoglobulin light chain gene: b) a plurality of pseudogene light chain variable regions each encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of the same 2 to 5 different amino acids as the CDRs of the functional gene; and ii. a light chain framework that is identical in amino acid sequence to the light chain framework of the transcribed variable region.Type: GrantFiled: June 1, 2018Date of Patent: January 8, 2019Assignee: Crystal Bioscience Inc.Inventors: William Don Harriman, Robert Etches, Philip A. Leighton
-
Patent number: 10010058Abstract: A transgenic animal is provided. In certain embodiments, the transgenic animal comprises a genome comprising: an immunoglobulin light chain locus comprising: a) a functional immunoglobulin light chain gene comprising a transcribed variable region encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of 2 to 5 different amino acids; and ii. a light chain framework; and, operably linked to the functional immunoglobulin light chain gene: b) a plurality of pseudogene light chain variable regions each encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of the same 2 to 5 different amino acids as the CDRs of the functional gene; and ii. a light chain framework that is identical in amino acid sequence to the light chain framework of the transcribed variable region.Type: GrantFiled: December 13, 2016Date of Patent: July 3, 2018Assignee: Crystal Bioscience Inc.Inventors: William Don Harriman, Robert Etches, Philip A. Leighton
-
Patent number: 9809642Abstract: A transgenic chicken comprising an inactivated heavy immunoglobulin gene and/or inactivated light chain immunoglobulin gene is provided, as well as cells and targeting vectors for making the same.Type: GrantFiled: May 27, 2016Date of Patent: November 7, 2017Assignee: Crystal Bioscience Inc.Inventors: Philip A. Leighton, William Don Harriman, Robert Etches
-
Patent number: 9380769Abstract: A transgenic chicken comprising an inactivated heavy immunoglobulin gene and/or inactivated light chain immunoglobulin gene is provided, as well as cells and targeting vectors for making the same.Type: GrantFiled: May 23, 2012Date of Patent: July 5, 2016Assignee: Crystal Bioscience Inc.Inventors: Phil Leighton, William Don Harriman, Robert Etches
-
Patent number: 8865462Abstract: A sustained culture of isolated avian gonocytes is provided, as well as a method of making and using the same. A chimeric avian containing an isolated gonocyte and a transgenic avian produced using the chimeric avian are also provided. The cell and method may be employed to make, among other things, transgenic avian that produce a heterologous protein, e.g., a therapeutic protein.Type: GrantFiled: January 7, 2011Date of Patent: October 21, 2014Assignee: Crystal Bioscience Inc.Inventors: Marie-Cecile van de Lavoir, Robert Etches
-
Publication number: 20140082759Abstract: A transgenic chicken comprising an inactivated heavy immunoglobulin gene and/or inactivated light chain immuno -well as globulin gene is provided, as we cells and targeting vectors for making the same.Type: ApplicationFiled: May 23, 2012Publication date: March 20, 2014Applicant: Crystal Bioscience Inc.Inventors: Phil Leighton, William Don Harriman, Robert Etches
-
Patent number: 8592644Abstract: A transgenic animal is provided. In certain embodiments, the transgenic animal comprises a genome comprising: an immunoglobulin light chain locus comprising: a) a functional immunoglobulin light chain gene comprising a transcribed variable region encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of 2 to 5 different amino acids; and ii. a light chain framework; and, operably linked to the functional immunoglobulin light chain gene: b) a plurality of pseudogene light chain variable regions each encoding: i. light chain CDR1, CDR2 and CDR3 regions that are composed of the same 2 to 5 different amino acids as the CDRs of the functional gene; and ii. a light chain framework that is identical in amino acid sequence to the light chain framework of the transcribed variable region.Type: GrantFiled: August 11, 2010Date of Patent: November 26, 2013Assignee: Crystal Bioscience Inc.Inventors: William Don Harriman, Robert Etches, Phil Leighton
-
Patent number: 8415173Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: August 26, 2011Date of Patent: April 9, 2013Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman
-
Patent number: 8030095Abstract: A gel microdrop composition is provided. In certain embodiments, the gel microdrop composition contains a polymer matrix, an effector particle that releases an effector molecule into the polymer matrix, a first reporter particle that emits a first optically detectable signal and a second reporter particle that emits a second optically detectable signal that is distinguishable from the first optically detectable signal, where the effector particle and said first and second reporter particles are encapsulated by the polymer matrix. Methods of screening that employ the gel microdrop composition and methods of making the gel microdrop composition are also disclosed.Type: GrantFiled: March 2, 2009Date of Patent: October 4, 2011Assignee: Crystal Bioscience Inc.Inventor: William Don Harriman